

The use of augmentation techniques in osteoporotic fracture fixation
Christian Kammerlander
a,b,
*, Carl Neuerburg
a
, Jorrit-Jan Verlaan
c
, Werner Schmoelz
b
, Theodore Miclau
d
,
Sune Larsson
e
a
Department of Trauma Surgery, Munich University Hospital LMU, Nußbaumstr. 20, 80336 Munich, Germany
b
Department of Trauma Surgery and Sportsmedicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
c
Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands
d
Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, San Francisco, University of California, San Francisco, San Francisco, CA, United States
e
Department of Orthopedics, Uppsala University Hospital, Uppsala, Sweden
A B S T R A C T
There are an increasing number of fragility fractures, which present a surgical challenge given the reduced bone
quality of underlying osteoporosis. Particularly in aged patients, there is a need for early weight bearing and
mobilization to avoid further complications such as loss of function or autonomy. As an attempt to improve
fracture stability and ultimate healing, the use of biomaterials for augmentation of osseous voids and fracture
fixation is a promising treatment option. Augmentation techniques can be applied in various locations, and
fractures of the metaphyseal regions such as proximal humerus, femur, tibia and the distal radius remain the most
common areas for its use. The current review, based on the available mechanical and biological data, provides an
overview of the relevant treatment options and different composites used for augmentation of osteoporotic
fractures.
© 2016 Elsevier Ltd. All rights reserved.
K E Y W O R D S
Fragility fractures
Augmentation
Cement
Biomaterials
Osteoporosis
Hip fracture
Distal radius fracture
Vertebral fracture
Proximal tibia fracture
Introduction
Fragility fractures are of increasing importance in orthopaedic
trauma surgery given the demographic changes of our aging
population. The National Osteoporosis Foundation estimates that
there are approximately 2 million osteoporosis-related fractures in
the U.S. each year, while additional studies suggest that the worldwide
burden is closer to 9 million [1,2]. Thus, a majority of fractures are
associated with osteoporosis, which result in 36% of the annual in-
patient care costs, or 860 million
€
, in Germany alone [1]. Over the next
few decades the incidence of osteoporotic fractures is expected to
increase [2]. In these fragility fractures, surgical treatment can be
challenging given the reduced bone quality that particularly affects
the frequently fractured metaphyseal regions such as the proximal
humerus, proximal femur, distal radius, spine, and proximal tibia.
Postoperative non-union, screw cut-out, and implant migration are
common complications adversely affecting patient outcomes. In the
elderly patient population susceptible to fragility fractures, full weight
bearing and early mobilization are of paramount importance in
order to avoid the significant peri- and post-operative complications
associated with frequently present comorbidities. The one-year
mortality of hip fractures for example is up to 30% [3].
While advances in implant design such as locked plates have
addressed some of the challenging issues, there is still need to promote
fracture biology, augment bone defects, and improve surgical fixation
in the osteoporotic patient. The aim of this review is to provide
an overview of a history of bone augmentation, clinical problems
associated with osteoporotic fractures, and potential solutions to these
challenges through the use of various augmentation techniques.
Mechanical and biological characteristics in osteoporotic fractures
Age-related resorption of calcium from bone results in thinning
of both trabecular and cortical bone and an associated increase in
bone diameter [2]. These anatomic changes have a direct effect on
mechanical properties. As the density of bone decreases, there is a
commensurate decrease in the yield stress, elastic modulus of cortical
bone, and compressive strength of cancellous bone [2]. Additional
cellular and physiologic changes in the bone contribute to an impaired
healing potential; there is a decrease in the number, responsiveness,
and activity of mesenchymal progenitor cells, and signaling molecules.
There also is a decrease in vascularity and impaired osteoblast function
that affect both endochondral and periosteal osteogenesis [3].
*
Corresponding author: Kammerlander Christian, Department of Trauma Surgery, Munich
University Hospital LMU, Nußbaumstr. 20, 80336 Munich, Germany. Tel.: 0049-89-4400-
53147; Fax: +49 89 4400 54437.
E-mail address:
christian.kammerlander@med.uni-muenchen.de(C. Kammerlander).
Injury, Int. J. Care Injured 47S2 (2016) S36
–
S43
Contents lists available at ScienceDirect
Injury
journal homepage: www.
elsevier.com/locate/Injury0020-1383 / © 2016 Elsevier Ltd. All rights reserved.